1. 2021
  2. The association between wearable activity monitor metrics and performance status in oncology: a systematic review

    Kos, M., Pijnappel, E. N., Buffart, L. M., Balvers, B. R., Kampshoff, C. S., Wilmink, J. W., van Laarhoven, H. W. M. & van Oijen, M. G. H., Nov 2021, In: Supportive care in cancer. 29, 11, p. 7085-7099 15 p.

    Research output: Contribution to journalReview articleAcademicpeer-review

  3. Validation of the FACIT-Sp-12 in a Dutch cohort of patients with advanced cancer

    Damen, A., Visser, A., van Laarhoven, H. W. M., Leget, C., Raijmakers, N., van Roij, J. & Fitchett, G., Nov 2021, In: Psycho-oncology. 30, 11, p. 1930-1938 9 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  4. Towards Evidence-Based Analysis of Palliative Treatments for Stomach and Esophageal Cancer Patients: a Process Mining Approach

    Pijnenborg, P., Verhoeven, R., Firat, M., Laarhoven, H. V. & Genga, L., 31 Oct 2021, Proceedings - 2021 3rd International Conference on Process Mining, ICPM 2021. Di Ciccio, C., Di Francescomarino, C. & Soffer, P. (eds.). Institute of Electrical and Electronics Engineers Inc., p. 136-143 8 p. (Proceedings - 2021 3rd International Conference on Process Mining, ICPM 2021).

    Research output: Chapter in Book/Report/Conference proceedingConference contributionAcademicpeer-review

  5. Met de huisarts in gesprek over het oncologische behandelbesluit

    Henselmans, I., Bos, D. W. & van Laarhoven, H. W. M., 8 Oct 2021, In: Nederlands tijdschrift voor geneeskunde. 165, 40

    Research output: Contribution to journalComment/Letter to the editorAcademic

  6. Phase i/ii study of lde225 in combination with gemcitabine and nab‐paclitaxel in patients with metastatic pancreatic cancer

    Pijnappel, E. N., Wassenaar, N. P. M., Gurney‐champion, O. J., Klaassen, R., van der Lee, K., Pleunis‐van Empel, M. C. H., Richel, D. J., Legdeur, M. C., Nederveen, A. J., van Laarhoven, H. W. M. & Wilmink, J. W., 1 Oct 2021, In: Cancers. 13, 19, 4869.

    Research output: Contribution to journalArticleAcademicpeer-review

  7. The association between effectiveness of first-line treatment and second-line treatment in gastro-oesophageal cancer

    van Velzen, M. J. M., Pape, M., Dijksterhuis, W. P. M., Slingerland, M., van Voorthuizen, T., Beerepoot, L. V., Creemers, G-J., Derks, S., Mohammad, N. H., Verhoeven, R. H. A. & van Laarhoven, H. W. M., 1 Oct 2021, In: European Journal of Cancer. 156, p. 60-69 10 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  8. Improved unsupervised physics-informed deep learning for intravoxel incoherent motion modeling and evaluation in pancreatic cancer patients

    Kaandorp, M. P. T., Barbieri, S., Klaassen, R., van Laarhoven, H. W. M., Crezee, H., While, P. T., Nederveen, A. J. & Gurney-Champion, O. J., Oct 2021, In: Magnetic resonance in medicine. 86, 4, p. 2250-2265 16 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  9. Met de huisarts in gesprek over het oncologische behandelbesluit

    Henselmans, I., Bos, D. W. & van Laarhoven, H. W. M., 30 Sept 2021, In: Nederlands tijdschrift voor geneeskunde. 165

    Research output: Contribution to journalArticleProfessional

  10. The Cellular Origins of Cancer-Associated Fibroblasts and Their Opposing Contributions to Pancreatic Cancer Growth

    Manoukian, P., Bijlsma, M. & van Laarhoven, H., 27 Sept 2021, In: Frontiers in cell and developmental biology. 9, 743907.

    Research output: Contribution to journalReview articleAcademicpeer-review

Previous 1...8 9 10 11 12 13 14 15 ...57 Next

ID: 97805